维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Lombo"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，12，6：	1
2	Combining sugar biosynthesis genes for the generation of L-and D-amicetose and formation of two novel antitumor tetracenomycins 显示文摘	PEREZ M LOMBO F ZHU L	2005	Chem Commun (Camb)2005，28，12：	1
3	Combinatorial biosynthesis of antitumor deoxysugar pathways in Streptomyces griseus: reconstitution of unnatural natural gene clusters for the biosynthesis of four 2,6-dideoxyhexoses 显示文摘	PEREZ M LOMBO F BAIG l	2006	Appl Environ Microbiol2006，72，10：	1
4	Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering显示文摘	Olano C Lombo F Mendez C	2008	Metab Eng2008，10，5：	1
5	Ticagrelor : the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Dtez JG	2011	Core Evid2011，6，：	1
6	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
7	Molecular control of ovule development显示文摘	Angenent G C Co lombo L	1996	Trends Plant Sci1996，，1：	1
8	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
9	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	LOMBO B DIEZ J G	2011	Core Evid2011，6，1：	1
10	Ticagrelor: Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez J G	2011	Core Evid2011，6，：	1
11	3-D transport and acoustic properties of Fontainebleau sandstone during true-triaxial deformation experiments显示文摘	M.H.B. Nasseri S.D. Goodfellow L. Lombos R.P. Young	2014	International Journal of Rock Mechanics and Mining Sciences2014，，：	1
12	Novel hybrid tetracenomycins through combinatorial biosynthesis using a glycosyltransferase encoded by elm genes in cosmid 16F4 and which shows a broad sugar substrate specificity显示文摘	Wohlert S E Blanco G Lombo F	1998	J Am Chem Soc1998，120，10：	1
13	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Jose Diez B Lombo	2011	2011 (default)2011，，：	1
14	Characterization of culture-positive adenovirus serotypes from respiratory specimens in Toronto, Ontario, Canada : September 2007-June 2008 显示文摘	Yeung R Eshaghi A Lombos E	2009	Virol J2009，6，：	1
15	Engineering biosynthetic pathways for deoxysugars:branched-chain sugar pathways and derivatives from the antitumor tetracenomycin显示文摘	Lombo F Gibson M Greenwell L	2004	Chem Biol2004，11，12：	1
16	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，：	1
17	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients w ith acute coronary syndromes显示文摘	Lombo B Diez J G	2011	Core Evid2011，6，：	1
18	Deciphering the biosynthesis pathway of the antitumor thiocor- aline from a marine actinomycete and its expression in two Streptomyces species显示文摘	Lombo F Velasco A Castro A	2006	ChemBioChem2006，7，2：	1
19	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	LOMBO B DIEZ JG	2011	Core Evid2011，6，：	1
20	An ABC transporter is essential for resistance to the antitumor agent mithramycin in the producer Streptomyces argillaceus显示文摘	Fernandez E Lombo F Mendez C	1996	Molecular and General Genetics1996，251，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示